1092698-84-4

Basic information

• Product Name: 2-(3-bromophenyl)-N-[(1S,2S)-1-hydroxy-1-phenylpropan-2-yl]-N-methylacetamide
• Synonyms: 2-(3-bromophenyl)-N-[(1S,2S)-1-hydroxy-1-phenylpropan-2-yl]-N-methylacetamide
• CAS NO: 1092698-84-4
• Molecular Weight: 362.266
• Mol File: 1092698-84-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(3-bromophenyl)-N-[(1S,2S)-1-hydroxy-1-phenylpropan-2-yl]-N-methylacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-bromophenyl)-N-[(1S,2S)-1-hydroxy-1-phenylpropan-2-yl]-N-methylacetamide(1092698-84-4)
• EPA Substance Registry System: 2-(3-bromophenyl)-N-[(1S,2S)-1-hydroxy-1-phenylpropan-2-yl]-N-methylacetamide(1092698-84-4)

Safety Data

• Hazardous Substances Data: 1092698-84-4(Hazardous Substances Data)

Upstream product

• 1878-67-7 3-Bromophenylacetic acid 
• 345-78-8 Novafed 

Downstream Products

• 1092698-85-5 (S)-2-(3-bromophenyl)-3-(4-chlorophenyl)-N-[(1S,2S)-1-hydroxy-1-phenylpropan-2-yl]-N-methylpropanamide 

Relevant articles and documents

Design, chemical synthesis, and biological evaluation of novel triazolyl analogues of taranabant (MK-0364), a cannabinoid-1 receptor inverse agonist

Being obese has various health problems that are related to type 2 diabetes mellitus, cardiovascular disease, hypertension, hyperlipidemia, and fibrinolytic abnormalities. Merck's taranabant (MK-0364), a CB1R inverse agonist, is currently in Phase 3 clini